Taken together, more studies are required to illustrate how mutations and variants of TMEM175 and pH changes, affect synucleinopathy etiology and progression as well as explain the dichotomous discrepancies in TMEM175 expression and PD pathology. This evidence concerns the gene TMEM175 and synucleinopathy.